Company
Is Mineralys Therapeutics Inc (NASDAQ: MLYS) Still A Buy After A -0.34% Weekly Drop?
During the last session, Mineralys Therapeutics Inc (NASDAQ:MLYS)’s traded shares were 0.44 million, with the beta value of the company hitting -0.31. At the end
